KindlyMD, Inc. (NASDAQ:NAKA - Get Free Report) shares shot up 8.3% during trading on Wednesday . The stock traded as high as $1.71 and last traded at $1.63. 13,522,952 shares were traded during mid-day trading, an increase of 219% from the average session volume of 4,234,305 shares. The stock had previously closed at $1.50.
Wall Street Analysts Forecast Growth
Separately, Maxim Group began coverage on KindlyMD in a report on Wednesday, September 3rd. They issued a "buy" rating and a $8.00 price objective on the stock. One research analyst has rated the stock with a Buy rating, According to MarketBeat.com, KindlyMD currently has an average rating of "Buy" and a consensus price target of $8.00.
Get Our Latest Report on NAKA
KindlyMD Stock Down 6.0%
The company has a 50-day moving average price of $8.04. The firm has a market capitalization of $529.38 million, a price-to-earnings ratio of -1.63 and a beta of 33.96.
KindlyMD (NASDAQ:NAKA - Get Free Report) last released its quarterly earnings data on Tuesday, August 5th. The company reported ($0.34) earnings per share (EPS) for the quarter. The business had revenue of $0.41 million for the quarter. KindlyMD had a negative return on equity of 131.09% and a negative net margin of 244.00%.
KindlyMD Company Profile
(
Get Free Report)
Kindly MD, Inc (“KindlyMD” or “Kindly”) is a Utah company formed in 2019. KindlyMD is a healthcare data company, focused on holistic pain management and reducing the impact of the opioid epidemic. KindlyMD offers direct health care to patients integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population.
Featured Articles
Before you consider KindlyMD, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and KindlyMD wasn't on the list.
While KindlyMD currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
We are about to experience the greatest A.I. boom in stock market history...
Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.
That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.
- The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
- The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
- Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.
Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.
And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...
Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
